RFK Jr. Cancels $500M in mRNA R&D Contracts as HHS Turns Focus to Older, Slower Vaccine Technologies - MedCity News
The U.S. Department of Health and Human Services is terminating mRNA vaccine research contracts for nearly $500 million due to reported ineffectiveness against respiratory infections.
Tremendous uncertainty' for cancer research as US officials target mRNA vaccines
Scientists fear that the restrictions on Covid mRNA vaccines may impede progress in mRNA cancer research, potentially stalling advancements in treating aggressive cancers such as pancreatic cancer.
How political attacks could crush the mRNA vaccine revolution
Donald Trump's second term's first day featured a major AI investment, signaling support for transformative mRNA technology intended for personalized cancer treatments.